The authority behind the standard

The UTI Institute is led by two of the field’s most recognised authorities in complex and recurrent urinary tract infection. Between them, decades of surgical practice, the UK’s foundational research literature, international teaching and parliamentary advisory work. This is not theoretical medicine – it is the standard, set by the people who defined it.

Mr Steve Foley

MBBS, FRCS (Urol) • Consultant Urological Surgeon

Clinical Co-Lead

A globally recognised authority in female and functional urology, whose work has shaped how recurrent and chronic UTI is diagnosed and treated

Female & functional urology
Phase III RCT investigator
Springer Nature co-editor
Male Sling pioneer

Professor Bob Yang

BSc (Hons), MBBS, FRCS (Urol) • Consultant Urological Surgeon

Clinical Co-Lead

A specialist in advanced UTI diagnostics and innovative therapeutic strategy, Professor Yang bridges molecular science and real-world urological practice, and leads the field’s definitive academic literature.

Molecular diagnostics
Phase III RCT investigator
Springer Nature lead editor
APPG on UTIs

Trusted on the world's leading platforms

Our clinical leads are regularly invited to teach, present and advise at:

Urinary tract infections are among the most prevalent infections globally, yet they remain critically underserved. For too long, patients have faced outdated diagnostics, a severe lack of research funding, and a reliance on oral antibiotics that disrupts the gut biome and fuels antimicrobial resistance. This status quo is unsustainable.

The UTI Institute was founded to change this paradigm. We aim to be the definitive hub for excellence, driving collaborative research, offering a trusted network of expert clinics, and delivering advanced, streamlined care. We are committed to leading the way in driving innovation, challenging the status quo, and ultimately transforming UTI care for patients globally.

Bob Yang – Director of the UTI Institute